Please sign in to follow a disease.
Can acupuncture help women who Can't get pregnant after multiple IVF attempts?
NCT ID NCT07669623
First seen Jun 26, 2026 · Last updated Aug 27, 2026 · Updated 5 times
Summary
This study tests whether different acupuncture techniques can increase pregnancy rates in women who have had at least two failed embryo transfers. 312 women aged 20-40 will be randomly assigned to receive either placebo needles, indwelling intradermal needles, or a combination of fire needle and regular acupuncture. The main goal is to see if any method leads to a detectable pregnancy on ultrasound.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acupuncture (nonpenetrating placebo needles, indwelling intradermal needles, fire needle plus regular acupuncture)
- What this could lead to
- If successful, this could offer a safe, non-drug option to improve pregnancy chances for women who have repeatedly failed embryo transfers.
- What could go wrong
- This is an early-stage trial with no phase, so results are uncertain. Acupuncture effects can be hard to measure, and the placebo group may also show benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 312 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Up to 39 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Meets the criteria for RIF diagnosis (≥ 3 instances of unsuccessful transfer of high-quality embryos). 2. Age: \< 40 years. 3. Planning for a cycle involving the transfer of frozen-thawed embryos (FET). 4. Possession of a transplantable frozen blastocyst (≥3BB). 5. Endometrial thickness \>7 mm within the period of endometrial transformation. Exclusion Criteria: 1. Individuals planning to undergo preimplantation genetic diagnosis (PGD). 2. Recipients of egg donations. 3. Chromosomal abnormalities in either spouse or one partner (excluding chromosomal polymorphisms). 4. Patients with known embryo-related factors leading to implantation failure. 5. Abnormalities of the uterus that may affect implantation (including uterine malformations, uterine tuberculosis, submucosal myomas, severe uterine adhesions, severe uterine endometriosis, myomas with a diameter of ≥4 cm, and so on). 6. Those with significant abnormalities in immunity or coagulation. 7. Individuals with other endocrine disorders, such as thyroid disorders, hyperprolactinemia, insulin resistance, diabetes, and adrenal disorders, whose hormone levels have not been well-controlled over the past 3 months. 8. Individuals with untreated hydrosalpinx; 9. Individuals with a Body Mass Index (BMI) below 18 and above 25 kg/ m2. 10. Men with severe abnormalities in semen quality. 11. Individuals with a history of needle phobia. 12. Individuals who have previously participated in this study or received acupuncture treatment within the past three months; 13. Any other conditions deemed unsuitable for participation by the researchers.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Implantation failure are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tongji Hospital,Tongji medical college,HUST
Wuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.